0:000:00
<p>Dr. Allison Zibelli and Dr. Rebecca Shatsky discuss advances in breast cancer research that were presented at the 2025 ASCO Annual Meeting, including a potential new standard of care for HER2+ breast cancer, the future of ER+ breast cancer management, and innovations in triple negative breast cancer therapy.</p> <h2>Transcript</h2> <p class="MsoNormal"><strong><span style= "font-family: 'Calibri',sans-serif;">Dr. Allison Zibelli:</span></strong> <span style= "font-family: 'Calibri',sans-serif;">Hello and welcome to the <em>ASCO Daily News</em> Podcast. I'm Dr. Allison Zibelli, your guest host of the podcast today. I'm an associate professor of medicine and a breast medical oncologist at the Sidney Kimmel Comprehensive Cancer Center at Jefferson Health.</span></p> <p class="MsoNormal"><span style= "font-family: 'Calibri',sans-serif;">There was a substantial amount of exciting breast cancer data presented at the 2025 ASCO Annual Meeting, and I'm delighted to be joined by Dr. Rebecca S...